BioNTech SE Reports Earnings Results for the First Quarter Ended March 31, 2026

Published: 2026-05-05 09:37:48 ET BNTX

Published on 05/05/2026 at 09:37 am EDT

BioNTech SE reported earnings results for the first quarter ended March 31, 2026. For the first quarter, the company reported sales was EUR 118.1 million compared to EUR 182.8 million a year ago. Net loss was EUR 531.9 million compared to EUR 415.8 million a year ago.

Basic loss per share from continuing operations was EUR 2.1 compared to EUR 1.73 a year ago. Diluted loss per share from continuing operations was EUR 2.1 compared to EUR 1.73 a year ago.